首页 > 最新文献

Organometallics最新文献

英文 中文
SY12-3 Treatment for oligometastatic NSCLC SY12-3 治疗寡转移性 NSCLC
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.677
H. Kenmotsu
{"title":"SY12-3 Treatment for oligometastatic NSCLC","authors":"H. Kenmotsu","doi":"10.1016/j.annonc.2024.07.677","DOIUrl":"10.1016/j.annonc.2024.07.677","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1303"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/S0923-7534(24)03952-8
{"title":"Title Page","authors":"","doi":"10.1016/S0923-7534(24)03952-8","DOIUrl":"10.1016/S0923-7534(24)03952-8","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page v"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SY7-3 That infusion is too much, isn't it? Consider the optimal infusion volume for patients with advanced cancer SY7-3 输液量太大了吧？考虑晚期癌症患者的最佳输液量
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.667
T. Ikari
{"title":"SY7-3 That infusion is too much, isn't it? Consider the optimal infusion volume for patients with advanced cancer","authors":"T. Ikari","doi":"10.1016/j.annonc.2024.07.667","DOIUrl":"10.1016/j.annonc.2024.07.667","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1295"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SY7-4 Prognostication in patients with advanced cancer in the last months of life SY7-4 晚期癌症患者生命最后几个月的预后分析
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.668
Y. Hiratsuka
{"title":"SY7-4 Prognostication in patients with advanced cancer in the last months of life","authors":"Y. Hiratsuka","doi":"10.1016/j.annonc.2024.07.668","DOIUrl":"10.1016/j.annonc.2024.07.668","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1295"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SY26-2 Development of ctDNA for MRD detection in breast cancer SY26-2 开发用于检测乳腺癌 MRD 的 ctDNA
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.691
Y. Ozaki
{"title":"SY26-2 Development of ctDNA for MRD detection in breast cancer","authors":"Y. Ozaki","doi":"10.1016/j.annonc.2024.07.691","DOIUrl":"10.1016/j.annonc.2024.07.691","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1296"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SY5-4 New treatment strategy for intermediate-stage hepatocellular carcinoma: combination of local and systemic therapy SY5-4 中晚期肝细胞癌的新治疗策略：局部和全身治疗相结合
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.665
K. Tsuchiya, Y. Yasui, N. Tamaki, H. Nakanishi, M. Kurosaki, N. Izumi
{"title":"SY5-4 New treatment strategy for intermediate-stage hepatocellular carcinoma: combination of local and systemic therapy","authors":"K. Tsuchiya, Y. Yasui, N. Tamaki, H. Nakanishi, M. Kurosaki, N. Izumi","doi":"10.1016/j.annonc.2024.07.665","DOIUrl":"10.1016/j.annonc.2024.07.665","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1297"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SY2-3 Development of treatments for TNBC other than immunotherapy SY2-3 开发免疫疗法以外的 TNBC 治疗方法
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.664
G. Curigliano
{"title":"SY2-3 Development of treatments for TNBC other than immunotherapy","authors":"G. Curigliano","doi":"10.1016/j.annonc.2024.07.664","DOIUrl":"10.1016/j.annonc.2024.07.664","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1293"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O15-2 Current status of distress screening among cancer patients: a survey of requirements in designated cancer care hospitals O15-2 癌症患者痛苦筛查现状：对指定癌症治疗医院要求的调查
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.655
J. Sakane , Y. Ito , M. Ota , I. Ueda , Y. Fujisaka , R. Rikitake , T. Watanabe , Y. Yamamoto , Y. Ichinose , M. Nino , M. Matsuki , T. Higashi , F. Wakao
{"title":"O15-2 Current status of distress screening among cancer patients: a survey of requirements in designated cancer care hospitals","authors":"J. Sakane , Y. Ito , M. Ota , I. Ueda , Y. Fujisaka , R. Rikitake , T. Watanabe , Y. Yamamoto , Y. Ichinose , M. Nino , M. Matsuki , T. Higashi , F. Wakao","doi":"10.1016/j.annonc.2024.07.655","DOIUrl":"10.1016/j.annonc.2024.07.655","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1323"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142525927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O5-3 Initiatives to improve the treatment opportunity using the patient-proposed healthcare services – the BELIEVE trial O5-3 利用患者提议的医疗服务改善治疗机会的倡议--BELIEVE 试验
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.639
K. Kondo , Y. Ando , T. Shimoi , K. Sunami , T. Shibata , Y. Hoshina , N. Okita , K. Nakamura , N. Yamamoto
{"title":"O5-3 Initiatives to improve the treatment opportunity using the patient-proposed healthcare services – the BELIEVE trial","authors":"K. Kondo , Y. Ando , T. Shimoi , K. Sunami , T. Shibata , Y. Hoshina , N. Okita , K. Nakamura , N. Yamamoto","doi":"10.1016/j.annonc.2024.07.639","DOIUrl":"10.1016/j.annonc.2024.07.639","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1317"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142525931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PS3-3 Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors PS3-3 伊非那他单抗德鲁司康（I-DXd；DS-7300）治疗晚期实体瘤的 1/2期临床和生物标志物数据
IF 56.7 3区 化学 Q2 CHEMISTRY, INORGANIC & NUCLEAR
Organometallics
Pub Date : 2024-10-01 DOI: 10.1016/j.annonc.2024.07.717
T. Doi , M.R. Patel , T. Koyama , G.S. Falchook , C. Friedman , S.A. Piha-Paul , M. Gutierrez , M. Awad , A. Mattour , T. Satoh , S. Takahashi , T. Tsunoda , S. Kadowaki , Y. Watanabe , N. Okamoto , H. Goto , N. Yoshizuka , M. Qian , X. Qian , M. Johnson
{"title":"PS3-3 Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors","authors":"T. Doi , M.R. Patel , T. Koyama , G.S. Falchook , C. Friedman , S.A. Piha-Paul , M. Gutierrez , M. Awad , A. Mattour , T. Satoh , S. Takahashi , T. Tsunoda , S. Kadowaki , Y. Watanabe , N. Okamoto , H. Goto , N. Yoshizuka , M. Qian , X. Qian , M. Johnson","doi":"10.1016/j.annonc.2024.07.717","DOIUrl":"10.1016/j.annonc.2024.07.717","url":null,"abstract":"","PeriodicalId":56,"journal":{"name":"Organometallics","volume":"35 ","pages":"Page S1315"},"PeriodicalIF":56.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Organometallics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1